Skip to main content
An official website of the United States government

Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Asefa, Wosene
 wosene.asefa@nih.gov
240-276-6422 		5E504 Program Support Assistant | Chemopreventive Agent Development
Biswas, Kajal, Ph.D.
 kajal.biswas2@nih.gov
240-276-5614 		5E540 Program Officer | Chemopreventive Agent Development
Cholewa, Brian, Ph.D.
 brian.cholewa@nih.gov
240-276-7545 		5E446 Deputy Chief | Chemopreventive Agent Development
Clifford, John, Ph.D.
 john.clifford@nih.gov
202-235-4482 		5E430 Program Officer | Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D.
 vignesh.gunasekharan@nih.gov
240-276-5814 		5E438 Program Officer | Chemopreventive Agent Development
Mohammed, Altaf, Ph.D.
 altaf.mohammed@nih.gov
240-276-6082 		5E542 Deputy Chief | Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S.
 ancy.nalli@nih.gov
202-276-5265 		5E536 Program Officer | Chemopreventive Agent Development
Sei, Shizuko, M.D.
 shizuko.sei@nih.gov
240-276-5005 		5E452 Co-Chief | Chemopreventive Agent Development
Shoemaker, Robert, Ph.D.
 robert.shoemaker@nih.gov
240-276-7077 		5E454 Co-Chief | Chemopreventive Agent Development
Acting Chief | Nutritional Science
Vlad, Anda, M.D., Ph.D.
 anda.vlad@nih.gov
240-276-6422 		5E538 Program Officer | Chemopreventive Agent Development

Grants

PI Name PI Organization Title Grant Number Program Official
Taouli, Bachir

Icahn School Of Medicine At Mount Sinai
United States

 Abbreviated MRI for HCC screening in cirrhotic patients 5R01CA249765-05 Guillermo Marquez, Ph.D.
Taratula, Oleh

Oregon State University
United States

 Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia 5R37CA234006-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tayob, Nabihah

Dana-Farber Cancer Inst
United States

 Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma 5R01CA230503-07 Nicholas Hodges, Ph.D.
Tearney, Guillermo J

Massachusetts General Hospital
United States

 Colorectal Cancer Screening with Optical Coherence Tomography 5R01CA280972-02 Matthew Young, Ph.D.
Temprosa, Marinella

George Washington University
United States

 22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center 2U01DK048489-28 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Temprosa, Marinella

George Washington University
United States

 22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center 2U01DK048489-28 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tennis, Meredith A

University Of Colorado Denver
United States

 Modeling lung squamous cell carcinoma premalignancy and prevention 1R01CA298925-01
Tennis, Meredith A

University Of Colorado Denver
United States

 Persistence and regression in lung premalignant lesions 1R01CA289576-01A1 Malgorzata Wojtowicz, M.D.
Terry, Kathryn L.

Brigham And Women'S Hospital
United States

 Changing Contraceptive Patterns and Ovarian Cancer Risk 5R01CA258679-05 Goli Samimi, Ph.D., M.P.H.
Tewari, Ashutosh K

Icahn School Of Medicine At Mount Sinai
United States

 Artificial intelligence enabled Stroma-Weighted Automated Grading system to improve risk stratification in Black Men 1R01CA290438-01A1 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Thakur, Mathew Laxman

Thomas Jefferson University
United States

 Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer 5R01CA249921-05
Thangaraju, Muthusamy

Augusta University
United States

 Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis 5R01CA275840-03
Thompson, Patricia Ann

University Of Arizona
United States

 University of Arizona Cancer Prevention Clinical Trials Network 2UG1CA242596-07 Donald Johnsey
Thompson, Patricia Ann

State University New York Stony Brook
United States

 Three-Arm randomized trial comparing the effect of aspirin, sulindac or no treatment control on breast density in patients with elevated breast cancer risk 5R01CA235720-05 Edward Sauter, M.D., Ph.D.
Tollefsbol, Trygve O

University Of Alabama At Birmingham
United States

 Combinatorial epigenetic-based prevention of breast cancer 5R01CA178441-10 Gabriela Riscuta, M.D., CNS